FICHA BIBLIOGRÁFICA Nº 1 (ENF PARASITARIAS) GRUPO B

Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi
human–host interactions

https://www.thelancet.com/action/showPdf?pii=S2666-5247%2821%2900265-2

Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose

primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a
four-arm, single-blind, phase 2/3, randomised trial

https://www.thelancet.com/pdfs/journals/lanmic/PIIS2666-5247(21)00192-0.pdf

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria

https://www.nejm.org/doi/pdf/10.1056/NEJMoa2104226?articleTools=true

Primaquine and Plasmodium vivax Malaria Recurrence in Brazil

https://www.nejm.org/action/showPdf?downloadfile=showPdf&doi=10.1056/
NEJMe2201725&loaded=true

The health-related quality of life in patients with Chagas disease: the state of the art

https://www.scielo.br/j/rsbmt/a/YpYJyx3YjbNqg3kfFHrLK7L/?format=pdf&lang=en

Electrocardiographic effect of artemisinin–piperaquine, dihydroartemisinin–piperaquine, and

artemether–lumefantrine treatment in falciparum malaria patients

https://www.scielo.br/j/rsbmt/a/wpWd7hgNQjrYQcznZzRFNrC/?format=pdf&lang=en

http://creativecommons.org/licenses/by-nc-nd/4.0/.

Serological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the
assessment of response to treatment in chronic Chagas diseas